Prime presents at 72nd Annual Roy A. Bowers Conference on Oct. 22 - Prime Therapeutics
Prime presents at 72nd Annual Roy A. Bowers Conference on Oct. 22
Mostafa Kamal, president and CEO of Prime Therapeutics will join panelists to discuss artificial intelligence—the myths, the reality and the not-too-distant future
Join industry leaders from across the country to gather leading experts, discuss health care issues and share solutions. The theme, “Emerging technologies and the future of healthcare — the impact of AI and regenerative medicine on patients, providers, payers and life sciences,” will take place at The Palace at Somerset Park in New Jersey, gathering pharmacists, physicians, nurses, pharmaceutical companies, state representatives and other health leaders.
Event:
72nd Annual Roy A. Bowers Conference
Educational session:
“Artificial intelligence — The myths, the reality and the not-too-distant future?”
Date/time:
Tuesday, Oct. 22 | 11:10–12:15 p.m. ET
Moderator:
- Heather Staples Lavoie, senior vice president of enterprise, business and technology solutions, CIO, Horizon Blue Cross Blue Shield of New Jersey
Panelists:
- Mostafa Kamal, president and CEO of Prime Therapeutics
- Vicente Gracias, M.D., FACS, FCCP, FCCM, professor, department of surgery, Robert Wood Johnson Medical School, senior vice chancellor for clinical affairs and vice present for health affairs, Rutgers, The State University of New Jersey.
- Tavani Patel, MBA, director and general manager of partner services, Amazon Pharmacy
About Prime Therapeutics
Prime Therapeutics LLC (Prime) offers innovative pharmacy benefit management, specialty and medical drug management, and state government solutions to millions of people across the country. At Prime, we’re reimagining pharmacy solutions to provide the care we’d want for our loved ones. That means we challenge the way it’s always been done to develop intelligently designed solutions that deliver savings, simplicity and support to our customers and members. For more information, follow us on LinkedIn.